Motixafortide API
Motixafortide ke peptide ea mohanyetsi oa CXCR4 e entsoeng ho bokella lisele tsa stem tsa hematopoietic (HSCs) bakeng sa phetisetso ea autologous mme e ntse e ithutoa ho oncology le immunotherapy.
Mokhoa le Lipatlisiso:
Motixafortide e thibela axis ea CXCR4-SDF-1, e lebisang ho:
Ho bokellana ha lisele tsa stem ka potlako maling a peripheral
Tšebeliso e matla ea lisele tsa 'mele le ho kenella ha tumor
Tšebelisano e ka bang teng le li-checkpoint inhibitors le chemotherapy
E bontšitse lihlahisoa tse phahameng tsa stem cell ha li bapisoa le bahlaseli ba teng litekong tsa meriana.
Likarolo tsa API (Gentolex Group):
Peptide ea maiketsetso e phahameng e hloekileng
Litekanyetso tsa tlhahiso tse kang GMP
E loketse litlhare tse nang le ente
Motixafortide API e tšehetsa lipatlisiso tse tsoetseng pele ho stem cell therapy le immunotherapy ea mofetše.